TLDR
- RKLB stock has risen 43.7% over the past year, far outpacing its industry peers.
- Cathie Wood’s ARK Investment Management bought over 705,000 RKLB shares across two sessions, worth roughly $44 million.
- Neutron’s end-of-year launch window is “narrowing,” according to CEO Peter Beck, making it both the biggest catalyst and the biggest risk.
- NASA awarded a $700 million Mars communications contract to Blue Origin, a blow to sentiment.
- RKLB’s backlog hit a record $2.36 billion, up 137% year over year, providing near-term revenue coverage.
Rocket Lab (RKLB) stock is trading around $62.54, down 2.2% on Tuesday and off more than 50% from its May record high. Despite the slide, ARK Investment Management has been buying aggressively, picking up 705,102 RKLB shares over two sessions for roughly $44 million.
That includes 504,799 purchased Tuesday alone across three ARK ETFs, worth about $31.6 million at Tuesday’s close.
The buying comes as RKLB has fallen in nine of its last 10 sessions, and then slipped further after hours.
Wall Street has trimmed price targets but has not walked away. Bank of America’s Ronald Epstein cut his target to $110 from $115 on August 31, partly to reflect a higher expected share count, but held his Buy rating. At Tuesday’s close, that revised target still implied around 76% upside.
Cantor Fitzgerald’s Andres Sheppard lifted his target to $122 from $96 after second-quarter results, calling Neutron “the most material catalyst.” Roth Capital’s Suji Desilva cut to $110 from $130 but kept his Buy rating, noting that the record backlog gives “meaningful near-term revenue coverage.”
Neutron Looms Large
Rocket Lab’s Neutron rocket is the central debate. The company wants it to open up the medium-lift launch market, expanding well beyond Electron’s small-satellite role.
But CEO Peter Beck said after Q2 results that the window for an inaugural launch by year-end is “narrowing.” Key testing milestones still need to be cleared before flight. If Neutron slips further, the growth case that underpins many of Wall Street’s high price targets gets pushed out.
The orbital launch market remains supply-constrained, which keeps Rocket Lab positioned to benefit if execution holds. Electron has already completed 87 missions, and HASTE supports government programs. Rocket Lab has more than 90 launches booked across Electron, HASTE, and Neutron.
NASA Blow and Record Backlog
Sentiment took another hit after Tuesday’s close when NASA awarded its Mars Telecommunications Network contract to Blue Origin. The firm-fixed-price deal is valued at up to $700 million, with Blue Origin tasked with delivering a Mars orbiter by the end of 2028. Rocket Lab had been eligible to compete.
The company’s Q2 2026 backlog hit a record $2.36 billion, up 137% from a year earlier. Around 45.5% of that backlog is expected to be recognized within 12 months.
The Mynaric and Motiv acquisitions, completed in recent quarters, added optical communications and robotics capabilities. Rocket Lab joined the U.S. Space Force’s NITE-STAR IDIQ program in August 2026, a contract with a $981 million ceiling covering space and ground systems.
RKLB’s EPS consensus estimate for 2026 has risen 44.44% over the past 60 days. Total debt to capital stands at 0.83%, well below the industry average of 61.47%. The current ratio is 5.48, versus an industry average of 2.06.
RKLB trades at 31.3X forward Price/Sales, a steep premium to its industry’s 7.64X.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
